Staying hydrated and planning meals remains important during the initial two weeks
An eGFR of 3044 indicates the presence of moderate-to-severe kidney disease, which is known as stage 3b
Step 2: Online Consultation Once verified, you will meet with a licensed provider through telehealth
Most of the animal research was done with first generation GLP-1 drugs, however clinical trials with human subjects using current versions of the drugs are now underway and look promising
Semaglutide is prescribed for lowering blood sugar levels for individuals with type 2 diabetes (T2D) and weight management for those who are overweight or have obesity with at least one weight-related comorbidity.[1-5] Individuals taking semaglutide may lose up to 15% of their body weight.[5] However, weight loss results may vary depending on your starting weight, comorbidities, other medications, and lifestyle choices.[1-5] Although the exact mechanism by which semaglutide causes weight loss is still under investigation, it has the potential to reduce appetite, thereby reducing caloric intake.[1-3] You may feel more tired than usual due to the reduced calorie intake while taking semaglutide